- Types of Eczema
- Child Eczema
- Causes & Triggers
- Living with Eczema
- Eczema Products
- Get Involved
Since 2004, NEA has been funding research to improve the health and quality of lives of individuals with eczema. The NEA Research Grant Program is supported through donations by our community members. A list of past NEA research grants can be found by here >
In 2015, NEA funded an audit of existing burden of disease peer-reviewed literature on pediatric and adult atopic dermatitis (AD), which revealed significant research gaps. As a result, NEA’s Scientific Advisory Committee and Board of Directors have identified three core priority areas for our 2016 Research Grant Program. 2016 requests for proposal include:
Sleep disruption is well documented in patients and families suffering from AD. Loss of sleep can adversely affect quality of life and can be associated with other co-morbidities ranging from ADHD to fracture risk. Current gaps in knowledge include how sleep patterns in individually affected patients vary with disease flares; how chronic sleep loss affects patients longitudinally; and how sleep quality rather than quantity is affected by AD and its treatment. This RFP seeks proposals at addressing these gaps.
A recent burden of disease audit confirmed that AD has a detrimental impact on the quality of life of patients and families. This impact is comparable to other chronic diseases including cystic fibrosis, renal disease, diabetes, and asthma. Gaps in current knowledge include: the current demographic of those affected; how this effect manifests across the AD spectrum, and how treatment can mitigate quality of life impact. This RFP seeks proposals aimed at assessing populations beyond tertiary care centers including pediatric, internal medicine, and family practice settings; how AD affects social interactions, intimacy, stigma and self-esteem; correlation of quality of life and AD severity; and, cost-effectiveness of therapy as it relates to quality of life.
Several small studies and a recent large global survey of patients with AD reveal that pain is a common symptom experienced by patients. There are currently no population-based studies defining the prevalence of pain in patients with AD. There are also no in-depth studies of pain severity or studies exploring the etiology of pain (e.g. secondary to excoriations or a primary consequence of the inflammation) in patients with AD. The impact of pain on the quality of life in patients with AD is also unknown. This RFP seeks proposals that shed light on the causes, severity, and contributing factors to the symptom of pain experienced by patients with AD. Studies may range from population-based large survey samples to smaller clinical samples using mixed qualitative and quantitative research methods.
Submissions must be received by Friday, September 16, 2016 at 5:00pm PDT. Grants will be awarded by December 2016, and project start-up is expected by January 1, 2017. Project completion is expected by the end of 2017.
An estimate of costs to conduct the research in a budget outline format is required for each RFP submission.
Describe your proposal in sufficient detail for adequate evaluation. Make every effort to be succinct. Please do not exceed 10 pages.
Please submit your proposal to National Eczema Association (NEA) at firstname.lastname@example.org
Subject Line: NEA 2016 Research Grant Proposal Submission
For additional information and application instructions, please contact Leda Simonsen, Executive Assistant: email@example.com or 415.499.3474.